Dr. Chronos received
a Bachelors degree in Medicine and Surgery
from the Royal Free Hospital School of Medicine
in London in 1987. Following, he trained
in cardiology and subsequently interventional
cardiology under the direction of Professors
Ulrich Sigwart and Anthony Rickards at the
Royal Brompton National Heart and Lung Institute.
In 1992, he was awarded a British Heart
Foundation International Fellowship and
moved to the United States to continue his
research in thrombosis and interventional
cardiology at Emory University School of
Medicine under the direction of Spencer
B. King, III, M.D.
He was named
Director of Research at the Andreas Gruentzig
Cardiovascular Center at Emory University
Hospital in 1997. Dr. Chronos is a Fellow
of the Royal College of Physicians (London),
Fellow of the American College of Cardiology,
and Fellow of the European Society of Cardiology,
and Fellow of the American Heart Association.
He has served on the Data Safety Monitoring
Board (ClinTrials Research), NIRVANA (Boston
Scientific), and SCORES (Scimed Life Systems).
He was named
Co-National Principal Investigator with
Professor Mike Simmons on the FIRST study,
the largest human clinical trial of angiogenesis.
Currently Dr. Chronos is conducting two
large clinical trials that use autologous
or umbilical cord stem cells to repair damaged
cardiac muscle. Dr. Chronos has also served
on the Steering Committees for various studies
RFPMR (Boston Scientific), TARGET (Merck
& Co., Inc.), and FIRST (Chiron Corporation).
Dr. Chronos has published over 200 peer-reviewed
papers.His publications include articles
in the Journal of the American College of
Cardiology, Circulation, Heart and European
Journal of Cardiology. He is an editorial
consultant to the New England Journal of
Medicine, British Heart Journal, Clinical
Science, the Journal of the American College
of Cardiology, Circulation, Heart, Atherosclerosis,
Catheterization and Cardiovascular Interventions,
Stent, Thrombosis Research, Cardiovascular
Radiation Medicine, Journal of Stem Cells
and other distinguished peer reviewed journals.Dr.
Chronos was appointed President of the Saint
Joseph’s Translational Research Institute
and has been named a Fellow of Saint Joseph’s
Heart and Vascular Institute.
Dr. Chronos has been associated with Saint
Joseph’s Hospital for nearly a decade.
World-renowned for his pioneering research
in angiogenesis, he is an Adjunct Professor
of Cardiology and Medicine at Duke University.
As President of Saint Joseph’s Translational
Research Institute, Dr. Chronos will continue
to direct, oversee pre-clinical research
and participate in clinical trials.
|
